Package Leaflet: Information for the User
Ornibel 0.120 mg/0.015 mg every 24 hours, vaginal EFG release system
(Etonogestrel/Ethinylestradiol)
Important things you should know about combined hormonal contraceptives (CHCs):
Read the entire package leaflet carefully before starting to use Ornibel, as it contains important information for you.
Contents of the Package Leaflet
2.1 When not to use Ornibel
2.2 Warnings and precautions
Blood Clots
Cancer
2.3 Children and adolescents
2.4 Other medicines and Ornibel
Lab tests
2.5 Pregnancy and breastfeeding
2.6 Driving and using machines
3.1 How to put on and remove Ornibel
3.2 Three weeks in, one week out
3.3 When to start with the first ring
3.4 What to do if…
Your ring is accidentally expelled from the vagina
Your ring has been out of the vagina temporarily
The ring opens
You have put on more than one ring
If you forget to put on a new ring after the ring-free break
If you have forgotten to remove the ring
If your period or menstrual bleeding does not occur
If you have unexpected bleeding
If you want to change the day your period or menstrual bleeding starts
If you want to delay your period or menstrual bleeding
3.5 If you want to stop using Ornibel.
Composition of Ornibel
Appearance of Ornibel and package contents
Marketing Authorization Holder and Manufacturer
Ornibel is a vaginal contraceptive ring used to prevent pregnancy. Each ring contains a small amount of two female sex hormones, etonogestrel and ethinylestradiol. The ring slowly releases these hormones into the bloodstream. Given the small amount of hormones released, Ornibel is a low-dose hormonal contraceptive.
As Ornibel releases two different types of hormones, it is a combined hormonal contraceptive
Ornibel works like the combined contraceptive pill (the "Pill"), but instead of taking a pill every day, the ring is used for 3 consecutive weeks. Ornibel releases two female sex hormones that prevent the ovaries from releasing an egg. If no egg is released, you cannot become pregnant
General considerations
Before starting to use Ornibel, you should read the information about blood clots in section 2. It is particularly important that you read the symptoms of a blood clot (see section 2 "Blood clots").
In this prospectus, various situations are described in which you should stop using Ornibel, or in which Ornibel may be less reliable. In these situations, you should not have sexual intercourse, or you should take additional non-hormonal contraceptive measures, such as a condom or another barrier method. Do notuse the rhythm method or the temperature method. These methods may not be reliable since Ornibel alters the monthly temperature changes of the body and cervical mucus.
Ornibel, like other hormonal contraceptives, does not protect against HIV infection (AIDS) or any other sexually transmitted disease.
2.1 When you should not use Ornibel
You should not use Ornibel if you have any of the conditions listed below. Inform your doctor if you have any of the conditions listed below. Your doctor will discuss with you what other form of contraception would be more suitable.
If any of these circumstances occur for the first time while using Ornibel, remove the ring immediately and consult your doctor. In the meantime, use non-hormonal contraceptive measures.
Do not use Ornibel if you have hepatitis C or are taking medications that contain ombitasvir/paritaprevir/ritonavir and dasabuvir or glecaprevir/pibrentasvir or sofosbuvir/velpatasvir/voxilaprevir (see also section 2.4 "Use of Ornibel with other medications")
2.2 Warnings and precautions
When should you consult your doctor?
Seek urgent medical attention
To obtain a description of the symptoms of these serious side effects, see "How to recognize a blood clot"
Tell your doctor if you suffer from any of the following conditions.
If the condition develops or worsens while you are using Ornibel, you should also inform your doctor.
BLOOD CLOTS
The use of a combined hormonal contraceptive like Ornibel increases your risk of having a blood clot compared to not using it. In rare cases, a blood clot can block blood vessels and cause serious problems.
Blood clots can form:
Recovery from blood clots is not always complete. In rare cases, there can be serious long-term effects or, very rarely, they can be fatal.
It is essential to remember that the overall risk of a harmful blood clot due to Ornibel is small.
HOW TO RECOGNIZE A BLOOD CLOT
Seek urgent medical attention if you notice any of the following signs or symptoms.
Are you experiencing any of these signs? | What might you be suffering from? |
| Deep vein thrombosis |
If you are unsure, consult a doctor, as some of these symptoms, such as cough or shortness of breath, can be confused with a milder condition such as a respiratory infection (e.g., a "common cold"). | Pulmonary embolism |
Symptoms that occur more frequently in one eye:
| Retinal vein thrombosis (blood clot in the eye). |
| Heart attack. |
Sometimes the symptoms of a stroke can be brief, with almost immediate and complete recovery, but you should still seek urgent medical attention as you may be at risk of having another stroke. | Stroke |
| Blood clots that block other blood vessels. |
BLOOD CLOTS IN A VEIN
What can happen if a blood clot forms in a vein?
When is the risk of having a blood clot in a vein higher?
The risk of having a blood clot in a vein is higher during the first year you take a combined hormonal contraceptive for the first time. The risk may also be higher if you start taking a combined hormonal contraceptive (the same medicine or a different one) after an interruption of 4 weeks or more.
After the first year, the risk decreases, but it is always slightly higher than if you were not taking a combined hormonal contraceptive.
When you stop using Ornibel, your risk of having a blood clot returns to normal within a few weeks.
What is the risk of having a blood clot?
The risk depends on your natural risk of VTE and the type of combined hormonal contraceptive you are taking.
The overall risk of having a blood clot in the leg or lung (DVT or PE) with Ornibel is small.
Risk of having a blood clot in a year | |
Women who do not usea combined hormonal contraceptive pill/patch/ring and are not pregnant | About 2 out of 10,000 women |
Women who use a combined hormonal contraceptive pill that contains levonorgestrel, norethisterone, or norgestimate | About 5-7 out of 10,000 women |
Women who use Ornibel | About 6-12 out of 10,000 women |
Factors that increase your risk of a blood clot in a vein
The risk of having a blood clot with Ornibel is small, but some conditions increase the risk. Your risk is higher:
The risk of having a blood clot increases with the number of conditions you have.
Long-distance air travel (more than 4 hours) may temporarily increase the risk of a blood clot, especially if you have any of the other risk factors listed.
It is essential to inform your doctor if you suffer from any of the above conditions, even if you are not sure. Your doctor may decide to stop you from using Ornibel.
If any of the above conditions change while you are using Ornibel, for example, a close relative experiences a thrombosis without a known cause or you gain a lot of weight, inform your doctor.
BLOOD CLOTS IN AN ARTERY
What can happen if a blood clot forms in an artery?
Like a blood clot in a vein, a clot in an artery can cause serious problems. For example, it can cause a heart attack or a stroke.
Factors that increase your risk of a blood clot in an artery
It is essential to note that the risk of a heart attack or stroke due to Ornibel is very small, but it can increase:
If you have one or more of these conditions or if any of them are particularly severe, the risk of having a blood clot may be increased further.
If any of the above conditions change while you are using Ornibel, for example, you start smoking, a close relative experiences a thrombosis without a known cause, or you gain a lot of weight, inform your doctor.
Cancer
The following information has been obtained from studies with combined oral contraceptives and may be applicable to Ornibel. No information is available on the administration of contraceptive hormones via the vaginal route (such as Ornibel).
Cases of breast cancer have been observed with a slightly higher frequency in women using oral contraceptives, but it is not known if this is due to the treatment. For example, it may be that more tumors are found in women using oral contraceptives because they undergo more frequent medical check-ups. This increased frequency decreases gradually after stopping treatment.
It is essential to examine your breasts regularly and inform your doctor if you notice any lump. Inform your doctor if any close relative has or has had breast cancer (see section 2.2 "Warnings and precautions").
Rare cases of benign liver tumors, and even more rarely, malignant liver tumors, have been reported in women using the oral contraceptive pill. Contact your doctor if you have severe and unusual abdominal pain.
In users of the combined pill, it has been observed that endometrial cancer (the tissue that lines the uterus) or ovarian cancer occurs less frequently. This may also be the case with Ornibel, but it has not been confirmed.
Psychiatric disorders:
Some women using hormonal contraceptives like Ornibel have reported depression or a depressed mood. Depression can be severe and sometimes can induce suicidal thoughts. If you experience mood changes and depressive symptoms, contact your doctor for additional medical advice as soon as possible.
2.3 Children and Adolescents
The safety and efficacy of Ornibel in adolescents under 18 years of age have not been established.
2.4 Other Medicines and Ornibel
Always inform your doctor about the medicines or herbal remedies you are taking. Also, inform any doctor or dentist (or pharmacist) who prescribes you another medicine that you are using Ornibel. They will be able to inform you if you need to take any additional contraceptive measures (for example, the use of male condoms) and if so, for how long, or if you should modify the use of the other medicine.
Some medicines
These include medicines used to treat:
If you are taking medicines or herbal remedies that could make Ornibel less effective, you should also use a barrier contraceptive method (e.g., male condom). Since the effect of another medicine on Ornibel can last up to 28 days after stopping the medicine, during that time, it is necessary to use an additional barrier contraceptive method. Note: Do not use Ornibel with a diaphragm, cervical cap, or female condom.
Ornibel may affect the effect of other medicines, for example:
Do not use Ornibel if you have Hepatitis C and are taking medicines containing omvitasvir/paritaprevir/ritonavir and dasabuvir or glecaprevir/pibrentasvir or sofosbuvir/velpatasvir/voxilaprevir, as these medicines may cause increases in blood parameters that measure liver function (increase in liver enzyme ALT).
Your doctor will prescribe another type of contraceptive before starting treatment with these medicines.
Ornibel can be restarted approximately 2 weeks after completing this treatment. See section 2.1 "When not to use Ornibel".
Consult your doctor or pharmacist before taking any medicine.
Tampons can be used while using Ornibel. First, insert Ornibel and then the tampon. Be careful when removing the tampon so that the ring is not accidentally expelled. If it is expelled, simply wash the ring with cold or warm water and reinsert it immediately.
The ring can be opened when using a vaginal product such as a lubricant or treatment for infection (see section 3.4 "What to do if... the ring opens")
The use of spermicides or products for vaginal fungi does not reduce the contraceptive efficacy of Ornibel.
Laboratory Tests
If you have blood or urine tests, inform your doctor that you use Ornibel, as it may affect the result of some tests.
2.5 Pregnancy and Breastfeeding
Pregnant women or those who suspect they may be pregnant should not use Ornibel. If you become pregnant while using Ornibel, you should remove the ring and consult your doctor.
If you want to stop using Ornibel because you want to become pregnant, see section 3.5 "If you want to stop using Ornibel".
In general, it is not recommended to use Ornibel while breastfeeding. If you want to use Ornibel while breastfeeding, consult your doctor.
2.6 Driving and Using Machines
It is unlikely that Ornibel will affect your ability to drive or use machines
You can put in and remove Ornibel yourself. Your doctor will tell you when to start using it for the first time. The vaginal ring should be inserted on the correct day of your menstrual cycle (see section 3.3 "When to start with the first ring") and remain in the vagina for 3 consecutive weeks. Regularly check if the ring is still in your vagina (e.g., before and after sexual intercourse) to ensure you are protected against pregnancy. After the third week, remove Ornibel and take a one-week break. You will normally have your menstrual period or bleeding during this ring-free break.
While using Ornibel, you should not use certain female barrier contraceptive methods, such as the vaginal diaphragm, cervical cap, or female condom. These barrier contraceptive methods should not be used as a backup contraceptive method because Ornibel may interfere with the correct placement and positioning of the diaphragm, cervical cap, or female condom. However, you can use a male condom as an additional barrier contraceptive method.
3.1 How to put in and remove Ornibel
When Ornibel is in place, you should not feel anything. If you feel uncomfortable, gently push Ornibel further into the vagina. The exact position of the ring inside the vagina is not important.
Figure 1
Remove Ornibel from its packaging
Figure 2
Press the ring
Figure 3
Choose a comfortable position to put in the ring
Figure 4A Figure 4B Figure 4C
Put the ring in the vagina with one hand (Figure 4A), if necessary, separate the vaginal lips with the other hand. Push the ring into the vagina until it feels comfortable (Figure 4B). Leave the ring in the vagina for 3 weeks (Figure 4C).
Figure 5:
Ornibel can be removed by hooking the ring with the index finger or holding it between the index and middle fingers and pulling it out.
3.2 Three weeks in, one week out
If you put in a new ring more than 3 hours late, the contraceptive effectiveness may be reduced. Follow the instructions in section 3.4 "What to do if you forget to put in a new ring after the ring-free break".
If you use Ornibel as described above, your bleeding will take place approximately on the same days each month.
3.3 When to start with the first ring
Put in Ornibel on the first day of your natural cycle (i.e., the first day of your menstruation). Ornibel starts working immediately. You do not need to take any other contraceptive measures.
You can also start with Ornibel between the 2nd and 5th day of your cycle, but if you have sexual intercourse during the first 7 days of using Ornibel, make sure to use a complementary contraceptive method (condom). You should only follow this recommendation when using Ornibel for the first time.
Start using Ornibel no later than the day after the break with your current pill. If the packaging of your pill also contains inactive tablets, start Ornibel no later than the day after the last inactive tablet. If you are unsure which tablet is which, consult your doctor or pharmacist. Never extend the break days of your current pill beyond what is recommended.
If you have taken your current pill continuously and correctly and are sure you are not pregnant, you can also stop taking the pill on any day of your current cycle and start with Ornibel immediately.
Start using Ornibel no later than the day after the patch-free break. Do not extend the patch-free break days beyond what is recommended.
If you have used the patch continuously and correctly and are sure you are not pregnant, you can also remove the patch on any day and start with Ornibel immediately.
You can stop taking your progestin-only pill on any day and start Ornibel the next day at the same time. However, make sure to also use a complementary contraceptive method (condom) during the first 7 days of using the ring.
Start using Ornibel when you would normally receive the next injection or on the day the implant or IUS is removed. However, make sure to use a complementary contraceptive method (condom) during the first 7 days of using the ring.
If you have just given birth, your doctor may advise you to wait until your first normal period appears before starting with Ornibel. Sometimes it is possible to start earlier, and your doctor will advise you on how to do so. If you are breastfeeding and want to use Ornibel, you should consult your doctor first.
Consult your doctor.
3.4 What to do if...
The ring is accidentally expelled from the vagina
Ornibel can be accidentally expelled from the vagina, for example, if it is not inserted correctly, when removing a tampon, during sexual intercourse, if you have constipation, or if you have uterine prolapse (uterine descent). Therefore, you should regularly check if the ring is in your vagina (e.g., before and after sexual intercourse).
The ring has been out of the vagina temporarily
Ornibel may still protect you from pregnancy, but this will depend on how long it has been out of your vagina.
If the ring has been out of the vagina for:
By putting in a new ring, you will start a new 3-week cycle, and you may not have your period. However, you may experience intermenstrual bleeding or spotting during that cycle.
Choose this option only if you have used Ornibel continuously for the previous 7 days.
If Ornibel has been out of the vagina for an unknown period, you may not be protected from pregnancy. You should take a pregnancy test and consult your doctor before inserting a new ring.
The ring breaks
Ornibel can break. Vaginal injury associated with ring breakage has been reported. If you notice that Ornibel has broken, remove the ring and put in a new one as soon as possible. Take complementary contraceptive precautions (e.g., a male condom) for the next 7 days. If you have had sexual intercourse before noticing that the ring had broken, consult your doctor.
You have put in more than one ring
There are no reports of serious harm due to an overdose of Ornibel's hormones. If you have accidentally put in more than one ring, you may feel unwell (nausea), vomit, or experience vaginal bleeding. Remove the extra ring and contact your doctor if these symptoms do not disappear. You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount used.
If you forget to put in a new ring after the ring-free break
Your ring-free breakhas lasted more than 7 days. Put in a new ring in the vagina as soon as you remember. Take additional contraceptive measures (such as a male condom) if you have sexual intercourse during the next 7 days. If you have had sexual intercourse during this ring-free break, there is a possibility that you may be pregnant. In this case, inform your doctor immediately. The longer the ring-free break, the higher the risk of pregnancy.
If you forget to remove the ring
If your period or bleeding does not occur
If your period does not occur, but you have used Ornibel according to the instructions and have not taken any other medications, it is very unlikely that you are pregnant. Continue using Ornibel as usual. However, if you have two consecutive missed periods, you may be pregnant, so you should inform your doctor immediately. Do not put in the next Ornibel until your doctor has checked that you are not pregnant.
If your usual bleeding does not occur during the one-week break and you have deviated from the recommended regimen, there is a possibility that you may be pregnant, so you should contact your doctor before putting in a new ring.
If you experience unexpected bleeding
In some women, during the use of Ornibel, unexpected vaginal bleeding may occur between menstrual periods. You may need to use sanitary protection. However, continue using the ring as usual; do not remove it. If the bleeding continues, becomes heavier, or starts again, consult your doctor.
If you want to change the day your period or bleeding starts
If you use Ornibel according to the instructions, your menstrual period (withdrawal bleeding) will start during the ring-free break. If you want to change the day it starts, you must shorten (never lengthen) the ring-free break.
For example, if your period usually starts on a Friday, you can change it to a Tuesday, i.e., 3 days earlier, starting from the next month. Simply put in the next ring 3 days earlier than the usual day.
If the break is very short (e.g., 3 days or less), you may not have your usual bleeding. You may experience spotting (drops or spots of blood) or intermenstrual bleeding during the use of the next ring.
If you are unsure how to do this, consult your doctor.
If you want to delay your period or bleeding
Although it is not the recommended regimen, you can delay your period (withdrawal bleeding) by putting in a new ring immediately after removing the current ring, without taking the break between rings. You can leave the new ring in for up to 3 weeks. During the use of the new ring, you may experience spotting (drops or spots of blood) or irregular bleeding. When you want your period to start, simply remove the ring. Take the normal one-week break without a ring and then put in a new ring.
You can consult your doctor before deciding to delay your menstrual period.
3.5 If you want to stop using Ornibel
You can stop using Ornibel at any time you want. If you do not want to become pregnant, consult your doctor about other contraceptive methods.
If you stop using Ornibel because you want to become pregnant, it is recommended to wait until you have had your first natural period before trying to conceive. This will help you calculate the due date.
Like all medicines, this medicine may cause adverse effects, although not all people suffer from them. If you experience any adverse effect, especially if it is severe and persistent, or have any change in health that you think may be due to Ornibel, consult your doctor.
All women who take combined hormonal contraceptives are at a higher risk of developing blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)). For more detailed information on the different risks of taking combined hormonal contraceptives, see section 2 "What you need to know before using Ornibel".
Contact a doctor immediately if you experience any of the following symptoms of angioedema: swelling of the face, tongue, and/or throat and/or difficulty swallowing or urticaria with possible difficulty breathing (see also section "Warnings and precautions").
Users of the ring containing Etonogestrel / Ethinylestradiol have reported the following adverse effects:
Frequent:may affect up to 1 in 10 women.
Uncommon:may affect up to 1 in 100 women.
Rare:may affect up to 1 in 1,000 women.
The chances of having a blood clot may be higher if you have any other condition that increases this risk (see section 2 for more information on conditions that increase the risk of blood clots and symptoms of a blood clot).
Frequency not known(cannot be estimated from available data).
There have been reports of breast cancer and liver tumors in women using combined hormonal contraceptives. For more information, see section 2.2 Warnings and precautions, Cancer.
Ornibel may open. For more information, see section 3.4 What to do if...the ring opens.
Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es
Keep this medicine out of sight and reach of children.
If you discover that a child has been exposed to the hormones of Ornibel, ask your doctor for advice.
This medicine does not require any special storage temperature.
Store in the original packaging to protect it from light.
Ornibel should be inserted at least one month before its expiration date appears on the box and on each pouch after CAD. The expiration date is the last day of the month indicated.
Do not use Ornibel if you observe changes in the color of the ring or any visible sign of deterioration.
This medicine may pose a risk to the environment. Once removed, Ornibel should be returned to its pouch and closed properly. The closed pouch should be discarded with normal household waste or returned to the pharmacy for proper destruction in accordance with local regulations.
Do not throw it down the toilet. Like other medicines, do not throw unused or expired rings down the drains or in the trash.
Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Ornibel
Ornibel contains 8.25 mg of etonogestrel and 2.60 mg of ethinylestradiol. The ring releases etonogestrel and ethinylestradiol in an amount of 0.120 mg and 0.015 mg, respectively, over 24 hours, for a period of 3 weeks.
Appearance of Ornibel and Package Contents
Vaginal release system.
Ornibel is a flexible, transparent, colorless or almost colorless ring, measuring 54 mm in diameter and 4 mm in cross-section.
Each ring is packaged in an aluminum pouch. The pouch is presented in a cardboard box along with this prospectus and stickers for your calendar to help you remember when to insert or remove the ring.
Each box contains 1, 3, or 6 rings.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Exeltis Healthcare, S.L.
Avda. De Miralcampo 7.
Miralcampo Industrial Estate.
19200 Azuqueca de Henares. Guadalajara.
Spain
Manufacturer:
Laboratorios León Farma, S.A.
Navatejera Industrial Estate.
La Vallina s/n.
24193 Villaquilambre, León.
Spain.
This medicine is authorized in the Member States of the European Economic Area under the following name:
Date of the last revision of this prospectus:November 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)
The average price of ORNIBEL 0.120 MG/0.015 MG every 24 hours vaginal delivery system in October, 2025 is around 9.9 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.